- Home
- Healthcare
- Codeine Market
Codeine Market Size (USD 164.02 M) by 2032 By Type (Single-ingredient Codeine, Multi-ingredient Medications), By Application (Narcotic Analgesic, Antitussive, Others) and Regional Forecast to 2032
Detailed TOC of Global Codeine Market Research Report 2024(Status and Outlook)
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Codeine
1.2 Key Market Segments
1.2.1 Codeine Segment by Type
1.2.2 Codeine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Codeine Market Overview
2.1 Global Market Overview
2.1.1 Global Codeine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Codeine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Codeine Market Competitive Landscape
3.1 Global Codeine Sales by Manufacturers (2019-2024)
3.2 Global Codeine Revenue Market Share by Manufacturers (2019-2024)
3.3 Codeine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Codeine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Codeine Sales Sites, Area Served, Product Type
3.6 Codeine Market Competitive Situation and Trends
3.6.1 Codeine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Codeine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Codeine Industry Chain Analysis
4.1 Codeine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Codeine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Codeine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Codeine Sales Market Share by Type (2019-2024)
6.3 Global Codeine Market Size Market Share by Type (2019-2024)
6.4 Global Codeine Price by Type (2019-2024)
7 Codeine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Codeine Market Sales by Application (2019-2024)
7.3 Global Codeine Market Size (M USD) by Application (2019-2024)
7.4 Global Codeine Sales Growth Rate by Application (2019-2024)
8 Codeine Market Segmentation by Region
8.1 Global Codeine Sales by Region
8.1.1 Global Codeine Sales by Region
8.1.2 Global Codeine Sales Market Share by Region
8.2 North America
8.2.1 North America Codeine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Codeine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Codeine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Codeine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Codeine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Taiji
9.1.1 Taiji Codeine Basic Information
9.1.2 Taiji Codeine Product Overview
9.1.3 Taiji Codeine Product Market Performance
9.1.4 Taiji Business Overview
9.1.5 Taiji Codeine SWOT Analysis
9.1.6 Taiji Recent Developments
9.2 Mallinckrodt
9.2.1 Mallinckrodt Codeine Basic Information
9.2.2 Mallinckrodt Codeine Product Overview
9.2.3 Mallinckrodt Codeine Product Market Performance
9.2.4 Mallinckrodt Business Overview
9.2.5 Mallinckrodt Codeine SWOT Analysis
9.2.6 Mallinckrodt Recent Developments
9.3 TEVA
9.3.1 TEVA Codeine Basic Information
9.3.2 TEVA Codeine Product Overview
9.3.3 TEVA Codeine Product Market Performance
9.3.4 TEVA Codeine SWOT Analysis
9.3.5 TEVA Business Overview
9.3.6 TEVA Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Codeine Basic Information
9.4.2 Johnson and Johnson Codeine Product Overview
9.4.3 Johnson and Johnson Codeine Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Medreich
9.5.1 Medreich Codeine Basic Information
9.5.2 Medreich Codeine Product Overview
9.5.3 Medreich Codeine Product Market Performance
9.5.4 Medreich Business Overview
9.5.5 Medreich Recent Developments
9.6 Sanofi Aventis
9.6.1 Sanofi Aventis Codeine Basic Information
9.6.2 Sanofi Aventis Codeine Product Overview
9.6.3 Sanofi Aventis Codeine Product Market Performance
9.6.4 Sanofi Aventis Business Overview
9.6.5 Sanofi Aventis Recent Developments
9.7 Cipla
9.7.1 Cipla Codeine Basic Information
9.7.2 Cipla Codeine Product Overview
9.7.3 Cipla Codeine Product Market Performance
9.7.4 Cipla Business Overview
9.7.5 Cipla Recent Developments
9.8 Hikma
9.8.1 Hikma Codeine Basic Information
9.8.2 Hikma Codeine Product Overview
9.8.3 Hikma Codeine Product Market Performance
9.8.4 Hikma Business Overview
9.8.5 Hikma Recent Developments
9.9 Pharmaceutical Associates
9.9.1 Pharmaceutical Associates Codeine Basic Information
9.9.2 Pharmaceutical Associates Codeine Product Overview
9.9.3 Pharmaceutical Associates Codeine Product Market Performance
9.9.4 Pharmaceutical Associates Business Overview
9.9.5 Pharmaceutical Associates Recent Developments
9.10 Novartis
9.10.1 Novartis Codeine Basic Information
9.10.2 Novartis Codeine Product Overview
9.10.3 Novartis Codeine Product Market Performance
9.10.4 Novartis Business Overview
9.10.5 Novartis Recent Developments
9.11 Apotex
9.11.1 Apotex Codeine Basic Information
9.11.2 Apotex Codeine Product Overview
9.11.3 Apotex Codeine Product Market Performance
9.11.4 Apotex Business Overview
9.11.5 Apotex Recent Developments
9.12 Mylan
9.12.1 Mylan Codeine Basic Information
9.12.2 Mylan Codeine Product Overview
9.12.3 Mylan Codeine Product Market Performance
9.12.4 Mylan Business Overview
9.12.5 Mylan Recent Developments
9.13 Aristo Pharma GmbH
9.13.1 Aristo Pharma GmbH Codeine Basic Information
9.13.2 Aristo Pharma GmbH Codeine Product Overview
9.13.3 Aristo Pharma GmbH Codeine Product Market Performance
9.13.4 Aristo Pharma GmbH Business Overview
9.13.5 Aristo Pharma GmbH Recent Developments
9.14 Lannett Company
9.14.1 Lannett Company Codeine Basic Information
9.14.2 Lannett Company Codeine Product Overview
9.14.3 Lannett Company Codeine Product Market Performance
9.14.4 Lannett Company Business Overview
9.14.5 Lannett Company Recent Developments
9.15 Laboratoire Riva
9.15.1 Laboratoire Riva Codeine Basic Information
9.15.2 Laboratoire Riva Codeine Product Overview
9.15.3 Laboratoire Riva Codeine Product Market Performance
9.15.4 Laboratoire Riva Business Overview
9.15.5 Laboratoire Riva Recent Developments
10 Codeine Market Forecast by Region
10.1 Global Codeine Market Size Forecast
10.2 Global Codeine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Codeine Market Size Forecast by Country
10.2.3 Asia Pacific Codeine Market Size Forecast by Region
10.2.4 South America Codeine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Codeine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Codeine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Codeine by Type (2025-2030)
11.1.2 Global Codeine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Codeine by Type (2025-2030)
11.2 Global Codeine Market Forecast by Application (2025-2030)
11.2.1 Global Codeine Sales (Kilotons) Forecast by Application
11.2.2 Global Codeine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
-
Download FREE Sample Report
Features |
Type of License |
|||
Single User |
Multi User |
Enterprise User |
||
Pricing | US$ 3480 | US$ 5220 | US$ 6960 | |
Number of Users Who can Access the Report |
1 user only |
2 to 10 users |
Unlimited
access within the organization |
|
Free Customization |
NA |
10% |
20% |
|
Permission to Print |
|
|
|
|
Complementary Analyst Support |
1 Month |
3 Months |
6 Months |
|
Access to the Analyst Team (through calls/email) |
Only Email |
|
|
|
Deliverable Format |
|
|
|
|
Word |
|
|
|
|
Excel |
|
|
|
|
Discount on Your Next Purchase (Applicable for only 1 Report on the sale license type) (offer Valid for a Month Only) |
No Discount |
10% |
20% |
|
Dedicated Account Manager |
|
|
|
|